Pyrazoloacridine Plus Carboplatin in Treating Patients With Recurrent Glioma

Completed · Phase 2

Conditions studied: Brain and Central Nervous System Tumors

In brief

Phase I/II trial to study the effectiveness of pyrazoloacridine plus carboplatin in treating patients who have recurrent glioma. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells.

Key facts

Study ID
NCT00005976
Run by
National Cancer Institute (NCI)
People needed
60
Starts
2000-05-01
Expected to finish
2007-04-01
Last updated by the study team
2013-06-03

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.